Displaying items by tag: University of the Sunshine Coast

Biotechnology firm Vaxxas has announced a Phase I clinical trial for the first needle-free COVID-19 vaccine candidate which is administered using Vaxxas' proprietary high-density microarray (HD-MAP) technology.

Published in Health

GUEST RESEARCH: The pandemic has accelerated the age of the consumer. For brands to survive, they need to anticipate and respond to consumer demands. The current global situation is challenging but it also offers opportunities for companies to get ahead, according to consumer intelligence company Talkwalker and customer relationship management platform HubSpot’s Social Media Trends Report.

Published in Guest Research

Subscribe to Newsletter

*  Enter the security code shown: img0

WEBINARS & EVENTS

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments